Most neurologists believe that CAR T-cell treatments have the potential to revolutionize care for neuro-immune diseases such as myasthenia…
Articles by Marisa Horak, MS
Myasthenia gravis (MG) can have a substantial impact on a person’s quality of life, but currently available data make…
Myasthenia gravis (MG) may be driven by antibody-producing immune B-cells going rogue in the thymus gland and developing escape…
Vyvgart (efgartigimod alfa-fcab), an approved treatment for myasthenia gravis (MG), can quickly and safely ease symptoms in people…
Top-line results — a snapshot of key early findings — from a large international clinical trial testing Immunovant’s therapy…
TPST-4003, Tempest Therapeutics’ next-generation CAR T-cell therapy for autoimmune diseases such as myasthenia gravis (MG), will soon be…
To successfully navigate life with myasthenia gravis (MG), people need to be aware of their own bodies and limitations,…
The Muscular Dystrophy Association (MDA) is hosting a series of four free, in-person educational events across the U.S. to support…
June is Myasthenia Gravis Awareness Month, and advocates around the world are planning a range of events to raise awareness…
Top-line results from a global, late-stage clinical trial testing the experimental cell therapy Descartes-08 against a placebo in adults with…